BMCS Hot Topics: Peptides in Drug Discovery
Event
BMCS Hot Topics: Peptides in Drug Discovery
Dates
Wednesday 6th May 2026 (afternoon) 13:00 – 17:00 UK Time
Place
Online event, Zoom
Important links and downloads
Social Media – #HotTopicsPDD
Please click here to register
Synopsis
The BMCS Hot Topics online meetings are intended to highlight breaking areas of research in fields of science relevant to drug discovery. They will run as stand-alone half-day virtual events, 2-3 times per year. The programme will be targeted towards researchers working who would like to enhance their understanding of these nascent or developing fields.
Peptides are a key modality for modulating biological pathways with the potential to enable mechanisms inaccessible to traditional small molecules. This meeting will showcase advances in peptide discovery and development, from cyclic and stapled scaffolds to strategies for achieving oral bioavailability. Talks will span discovery and optimisation technologies alongside chemistry strategies for stability, permeability, and delivery, with case studies charting progress from peptide leads to clinical candidates.
Registration
Registration is open. Please click here to register.
Please note that registrations are for one person per booking.
If you wish to register multiple people from the same organisation, we can offer a sizeable discount. If you are interested, please contact aimee.jackson@hg3.co.uk.
Registration fees:
RSC Member: £55.00
Non-Member: £75.00
RSC Student Member: £40.00
Student Non-Member: £50.00
Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.
Sponsorship
The organising committee are seeking sponsorship from organisations supporting the low registration fees offered to students. If you wish to sponsor, please click here.
All sponsors will receive the following:
– Logo and URL on the meeting website
– Logo on the holding slides shown during the breaks at the meeting
– Logo included in the delegate handbook
– One static slide to be included in the holding slides
Confirmed Speakers
Jim Aggen, Circle Pharma
Cyclin A/B RxL Inhibitors: A case study for achieving cell permeability and oral bioavailability in macrocyclic peptides
Organising Committee
Adrian Hall, UCB
Daniel O Donovan, AstraZeneca
Chris Swain, Cambridge MedChem Consulting
Hannah Fowler, RSC
Louise Walport, Imperial College
Marta Brambilla, Johnson & Johnson
Secretariat Contact
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail
